Literature DB >> 26732738

The natural history of severe asthma and influences of early risk factors: a population-based cohort study.

Wenjia Chen1, Carlo A Marra2, Larry D Lynd2, J Mark FitzGerald3, Zafar Zafari4, Mohsen Sadatsafavi3.   

Abstract

BACKGROUND: Severe asthma is associated with disproportionately high morbidity, but little is known about its natural history and how risk factors at first year of diagnosis modify its subsequent development.
METHODS: Using administrative health data, we retrospectively followed patients 14-55 years of age with newly diagnosed severe asthma in British Columbia, Canada. Based on intensity of resource use (drug therapy) and occurrence of exacerbations, each patient-year was classified into mild, moderate, or severe asthma. We estimated the probability of transition between severity levels or to death over the study period using a four-state Markov model, and used this to assess the 10-year trajectory of severe asthma and the influence of baseline risk factors.
RESULTS: We followed 13,467 patients. Ten years after incident severe asthma, 83% had transitioned to a less severe level (mild: 43%, moderate: 40%). Low socioeconomic status, high comorbidity burden, and high adherence (proportion of days covered (PDC) by asthma controller therapy) in the first year were independently associated with, respectively, 10%, 24% and 35% more time in severe asthma over the next 10 years. Sex was not associated with the clinical course.
CONCLUSIONS: Most patients with incident severe asthma used fewer resources over time, indicating a long-term transition to milder asthma. Potentially modifiable risk factors for poor prognosis of severe asthma include low socioeconomic status and high comorbidity burden. The association between PDC and future asthma severity is likely due to residual confounding by disease severity. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Asthma; Asthma Epidemiology; Asthma Guidelines; Clinical Epidemiology

Mesh:

Year:  2016        PMID: 26732738     DOI: 10.1136/thoraxjnl-2015-207530

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  15 in total

Review 1.  Asthma in the Americas: An Update: A Joint Perspective from the Brazilian Thoracic Society, Canadian Thoracic Society, Latin American Thoracic Society, and American Thoracic Society.

Authors:  Erick Forno; Diego D Brandenburg; Jose A Castro-Rodriguez; Carlos A Celis-Preciado; Fernando Holguin; Christopher Licskai; Stephanie Lovinsky-Desir; Marcia Pizzichini; Alejandro Teper; Connie Yang; Juan C Celedón
Journal:  Ann Am Thorac Soc       Date:  2022-04

2.  Evaluation of the use of Swedish integrated electronic health records and register health care data as support clinical trials in severe asthma: the PACEHR study.

Authors:  Stefan Franzén; Christer Janson; Kjell Larsson; Max Petzold; Urban Olsson; Gunnar Magnusson; Gunilla Telg; Gene Colice; Gunnar Johansson; Mats Sundgren
Journal:  Respir Res       Date:  2016-11-15

3.  Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population.

Authors:  Marjan Kerkhof; Trung N Tran; Joan B Soriano; Sarowar Golam; Danny Gibson; Elizabeth V Hillyer; David B Price
Journal:  Thorax       Date:  2017-09-16       Impact factor: 9.139

4.  Matched cohort study of therapeutic strategies to prevent preschool wheezing/asthma attacks.

Authors:  Jonathan Grigg; Anjan Nibber; James Y Paton; Alison Chisholm; Theresa W Guilbert; Alan Kaplan; Steve Turner; Nicolas Roche; Elizabeth V Hillyer; David B Price
Journal:  J Asthma Allergy       Date:  2018-12-11

5.  Dynamics of respiratory symptoms during infancy and associations with wheezing at school age.

Authors:  Jakob Usemann; Binbin Xu; Edgar Delgado-Eckert; Insa Korten; Pinelopi Anagnostopoulou; Olga Gorlanova; Claudia Kuehni; Martin Röösli; Philipp Latzin; Urs Frey
Journal:  ERJ Open Res       Date:  2018-11-20

6.  INITIAL - An observational study of disease severity in newly diagnosed asthma patients and initial response following 12 weeks' treatment.

Authors:  Jiangtao Lin; Xiuhua Fu; Ping Jiang; Weidong Song; Xiaoyun Hu; Zhijun Jie; Chuntao Liu; Zhengguang He; Xiangdong Zhou; Huaping Tang
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

Review 7.  Asthma in Children and Adults-What Are the Differences and What Can They Tell us About Asthma?

Authors:  Michelle Trivedi; Eve Denton
Journal:  Front Pediatr       Date:  2019-06-25       Impact factor: 3.418

Review 8.  Asthma progression and mortality: the role of inhaled corticosteroids.

Authors:  Paul O'Byrne; Leonardo M Fabbri; Ian D Pavord; Alberto Papi; Stefano Petruzzelli; Peter Lange
Journal:  Eur Respir J       Date:  2019-07-18       Impact factor: 16.671

Review 9.  Recent Developments In Bronchial Thermoplasty For Severe Asthma.

Authors:  Neil C Thomson
Journal:  J Asthma Allergy       Date:  2019-11-19

10.  FEV1 decline in relation to blood eosinophils and neutrophils in a population-based asthma cohort.

Authors:  Helena Backman; Anne Lindberg; Linnea Hedman; Caroline Stridsman; Sven-Arne Jansson; Thomas Sandström; Bo Lundbäck; Eva Rönmark
Journal:  World Allergy Organ J       Date:  2020-03-17       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.